UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 10-Q
[X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE QUARTERLY PERIOD ENDED MARCH 31, 2014
OR
[ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
FOR THE TRANSITION PERIOD FROM TO
____________________________________________________________________________
COMMISSION FILE NUMBER 1-11846
AptarGroup, Inc.
DELAWARE |
|
36-3853103 |
(State of Incorporation) |
|
(I.R.S. Employer Identification No.) |
475 WEST TERRA COTTA AVENUE, SUITE E, CRYSTAL LAKE, ILLINOIS 60014
815-477-0424
Indicate by check mark whether the registrant: (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the Registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes þ No o
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files). Yes þ No o
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of large accelerated filer, accelerated filer and smaller reporting company in Rule 12b-2 of the Exchange Act. (Check one):
Large accelerated filer þ |
|
Accelerated filer ¨ |
|
Non-accelerated filer ¨ |
|
Smaller reporting company ¨ |
|
|
|
|
(Do not check if a smaller reporting company) |
|
|
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ¨ No þ
Indicate the number of shares outstanding of each of the issuers classes of common stock, as of the latest practicable date.
Class |
|
Outstanding at April 30, 2014 |
Common Stock, $.01 par value per share |
|
65,453,658 shares |
AptarGroup, Inc.
Form 10-Q
Quarter Ended March 31, 2014
PART I FINANCIAL INFORMATION
ITEM 1. FINANCIAL STATEMENTS (UNAUDITED)
AptarGroup, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF INCOME
(Unaudited)
In thousands, except per share amounts
Three Months Ended March 31, |
|
2014 |
|
2013 |
| ||
|
|
|
|
|
| ||
Net Sales |
|
$ |
676,051 |
|
$ |
617,633 |
|
Operating Expenses: |
|
|
|
|
| ||
Cost of sales (exclusive of depreciation and amortization shown below) |
|
453,411 |
|
418,486 |
| ||
Selling, research & development and administrative |
|
106,674 |
|
94,307 |
| ||
Depreciation and amortization |
|
37,247 |
|
36,171 |
| ||
Restructuring initiatives |
|
-- |
|
4,067 |
| ||
|
|
597,332 |
|
553,031 |
| ||
Operating Income |
|
78,719 |
|
64,602 |
| ||
|
|
|
|
|
| ||
Other Income (Expense): |
|
|
|
|
| ||
Interest expense |
|
(4,881 |
) |
(5,081 |
) | ||
Interest income |
|
1,016 |
|
849 |
| ||
Equity results of affiliates |
|
(1,546 |
) |
(262 |
) | ||
Miscellaneous, net |
|
372 |
|
(706 |
) | ||
|
|
(5,039 |
) |
(5,200 |
) | ||
|
|
|
|
|
| ||
Income before Income Taxes |
|
73,680 |
|
59,402 |
| ||
|
|
|
|
|
| ||
Provision for Income Taxes |
|
25,272 |
|
19,424 |
| ||
|
|
|
|
|
| ||
Net Income |
|
48,408 |
|
39,978 |
| ||
|
|
|
|
|
| ||
Net (Income)/Loss Attributable to Noncontrolling Interests |
|
(19 |
) |
51 |
| ||
|
|
|
|
|
| ||
Net Income Attributable to AptarGroup, Inc. |
|
$ |
48,389 |
|
$ |
40,029 |
|
|
|
|
|
|
| ||
Net Income Attributable to AptarGroup, Inc. Per Common Share: |
|
|
|
|
| ||
Basic |
|
$ |
0.74 |
|
$ |
0.61 |
|
Diluted |
|
$ |
0.71 |
|
$ |
0.59 |
|
|
|
|
|
|
| ||
Average Number of Shares Outstanding: |
|
|
|
|
| ||
Basic |
|
65,468 |
|
66,155 |
| ||
Diluted |
|
68,232 |
|
68,296 |
| ||
|
|
|
|
|
| ||
Dividends per Common Share |
|
$ |
0.25 |
|
$ |
0.25 |
|
See accompanying Unaudited Notes to Condensed Consolidated Financial Statements.
AptarGroup, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE INCOME
(Unaudited)
In thousands
Three Months Ended March 31, |
|
2014 |
|
2013 |
| ||
|
|
|
|
|
| ||
Net Income |
|
$ |
48,408 |
|
$ |
39,978 |
|
Other Comprehensive Income (Loss): |
|
|
|
|
| ||
Foreign currency translation adjustments |
|
563 |
|
(35,613 |
) | ||
Changes in treasury locks, net of tax |
|
6 |
|
15 |
| ||
Defined benefit pension plan, net of tax |
|
|
|
|
| ||
Amortization of prior service cost included in net income, net of tax |
|
53 |
|
61 |
| ||
Amortization of net loss included in net income, net of tax |
|
665 |
|
1,118 |
| ||
Total defined benefit pension plan, net of tax |
|
718 |
|
1,179 |
| ||
Total other comprehensive income (loss) |
|
1,287 |
|
(34,419 |
) | ||
|
|
|
|
|
| ||
Comprehensive Income |
|
49,695 |
|
5,559 |
| ||
|
|
|
|
|
| ||
Comprehensive (Income)/Loss Attributable to Noncontrolling Interests |
|
(9 |
) |
50 |
| ||
|
|
|
|
|
| ||
Comprehensive Income Attributable to AptarGroup, Inc. |
|
$ |
49,686 |
|
$ |
5,609 |
|
See accompanying Unaudited Notes to Condensed Consolidated Financial Statements.
AptarGroup, Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
In thousands
|
|
March 31, |
|
December 31, |
| ||
|
|
2014 |
|
2013 |
| ||
|
|
|
|
|
| ||
Assets |
|
|
|
|
| ||
|
|
|
|
|
| ||
Current Assets: |
|
|
|
|
| ||
Cash and equivalents |
|
$ |
317,177 |
|
$ |
309,861 |
|
Accounts and notes receivable, less allowance for doubtful accounts of $5,063 in 2014 and $4,416 in 2013 |
|
505,505 |
|
438,221 |
| ||
Inventories |
|
358,709 |
|
353,159 |
| ||
Prepaid and other |
|
97,651 |
|
97,170 |
| ||
|
|
1,279,042 |
|
1,198,411 |
| ||
Property, Plant and Equipment: |
|
|
|
|
| ||
Buildings and improvements |
|
379,522 |
|
377,300 |
| ||
Machinery and equipment |
|
2,016,784 |
|
1,982,195 |
| ||
|
|
2,396,306 |
|
2,359,495 |
| ||
Less: Accumulated depreciation |
|
(1,550,359 |
) |
(1,518,894 |
) | ||
|
|
845,947 |
|
840,601 |
| ||
Land |
|
24,104 |
|
24,061 |
| ||
|
|
870,051 |
|
864,662 |
| ||
|
|
|
|
|
| ||
Other Assets: |
|
|
|
|
| ||
Investments in affiliates |
|
6,730 |
|
8,243 |
| ||
Goodwill |
|
359,681 |
|
358,865 |
| ||
Intangible assets, net |
|
48,964 |
|
49,951 |
| ||
Miscellaneous |
|
15,965 |
|
17,630 |
| ||
|
|
431,340 |
|
434,689 |
| ||
Total Assets |
|
$ |
2,580,433 |
|
$ |
2,497,762 |
|
See accompanying Unaudited Notes to Condensed Consolidated Financial Statements.
AptarGroup, Inc.
CONDENSED CONSOLIDATED BALANCE SHEETS
(Unaudited)
In thousands, except per share amounts
|
|
March 31, |
|
December 31, |
| ||
|
|
2014 |
|
2013 |
| ||
|
|
|
|
|
| ||
Liabilities and Stockholders Equity |
|
|
|
|
| ||
|
|
|
|
|
| ||
Current Liabilities: |
|
|
|
|
| ||
Notes payable |
|
$ |
173,284 |
|
$ |
138,445 |
|
Current maturities of long-term obligations |
|
1,004 |
|
1,325 |
| ||
Accounts payable and accrued liabilities |
|
411,506 |
|
403,051 |
| ||
|
|
585,794 |
|
542,821 |
| ||
|
|
|
|
|
| ||
Long-Term Obligations |
|
354,758 |
|
354,814 |
| ||
|
|
|
|
|
| ||
Deferred Liabilities and Other: |
|
|
|
|
| ||
Deferred income taxes |
|
40,780 |
|
42,072 |
| ||
Retirement and deferred compensation plans |
|
75,002 |
|
71,883 |
| ||
Deferred and other non-current liabilities |
|
5,213 |
|
5,864 |
| ||
Commitments and contingencies |
|
-- |
|
-- |
| ||
|
|
120,995 |
|
119,819 |
| ||
|
|
|
|
|
| ||
Stockholders Equity: |
|
|
|
|
| ||
AptarGroup, Inc. stockholders equity |
|
|
|
|
| ||
Common stock, $.01 par value, 199 million shares authorized; 85.6 and 85.4 million shares issued as of March 31, 2014 and December 31, 2013, respectively |
|
855 |
|
853 |
| ||
Capital in excess of par value |
|
512,192 |
|
493,947 |
| ||
Retained earnings |
|
1,651,442 |
|
1,619,419 |
| ||
Accumulated other comprehensive income |
|
111,048 |
|
109,751 |
| ||
Less treasury stock at cost, 20.1 and 20.0 million shares as of March 31, 2014 and December 31, 2013, respectively |
|
(757,211 |
) |
(744,213 |
) | ||
Total AptarGroup, Inc. Stockholders Equity |
|
1,518,326 |
|
1,479,757 |
| ||
Noncontrolling interests in subsidiaries |
|
560 |
|
551 |
| ||
|
|
|
|
|
| ||
Total Stockholders Equity |
|
1,518,886 |
|
1,480,308 |
| ||
Total Liabilities and Stockholders Equity |
|
$ |
2,580,433 |
|
$ |
2,497,762 |
|
See accompanying Unaudited Notes to Condensed Consolidated Financial Statements.
AptarGroup, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY
(Unaudited)
In thousands | ||||||||||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
|
|
AptarGroup, Inc. Stockholders Equity |
|
|
|
|
| |||||||||||||||
|
|
|
|
Accumulated |
|
|
|
|
|
|
|
|
|
|
| |||||||
|
|
|
|
Other |
|
Common |
|
|
|
Capital in |
|
Non- |
|
|
| |||||||
|
|
Retained |
|
Comprehensive |
|
Stock |
|
Treasury |
|
Excess of |
|
Controlling |
|
Total |
| |||||||
|
|
Earnings |
|
Income/(Loss) |
|
Par Value |
|
Stock |
|
Par Value |
|
Interest |
|
Equity |
| |||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Balance December 31, 2012: |
|
$ |
1,513,558 |
|
$ |
60,683 |
|
$ |
840 |
|
$ |
(625,401 |
) |
$ |
430,210 |
|
$ |
608 |
|
$ |
1,380,498 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Net income (loss) |
|
40,029 |
|
|
|
|
|
|
|
|
|
(51 |
) |
39,978 |
| |||||||
Foreign currency translation adjustments |
|
|
|
(35,614 |
) |
|
|
|
|
|
|
1 |
|
(35,613 |
) | |||||||
Changes in unrecognized pension gains/losses and related amortization, net of tax |
|
|
|
1,179 |
|
|
|
|
|
|
|
|
|
1,179 |
| |||||||
Changes in treasury locks, net of tax |
|
|
|
15 |
|
|
|
|
|
|
|
|
|
15 |
| |||||||
Stock option exercises & restricted stock vestings |
|
|
|
|
|
5 |
|
1 |
|
28,968 |
|
|
|
28,974 |
| |||||||
Cash dividends declared on common stock |
|
(16,493 |
) |
|
|
|
|
|
|
|
|
|
|
(16,493 |
) | |||||||
Treasury stock purchased |
|
|
|
|
|
|
|
(10,768 |
) |
|
|
|
|
(10,768 |
) | |||||||
Balance March 31, 2013: |
|
$ |
1,537,094 |
|
$ |
26,263 |
|
$ |
845 |
|
$ |
(636,168 |
) |
$ |
459,178 |
|
$ |
558 |
|
$ |
1,387,770 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Balance December 31, 2013: |
|
$ |
1,619,419 |
|
$ |
109,751 |
|
$ |
853 |
|
$ |
(744,213 |
) |
$ |
493,947 |
|
$ |
551 |
|
$ |
1,480,308 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||||||
Net income |
|
48,389 |
|
|
|
|
|
|
|
|
|
19 |
|
48,408 |
| |||||||
Foreign currency translation adjustments |
|
|
|
573 |
|
|
|
|
|
|
|
(10 |
) |
563 |
| |||||||
Changes in unrecognized pension gains/losses and related amortization, net of tax |
|
|
|
718 |
|
|
|
|
|
|
|
|
|
718 |
| |||||||
Changes in treasury locks, net of tax |
|
|
|
6 |
|
|
|
|
|
|
|
|
|
6 |
| |||||||
Stock option exercises & restricted stock vestings |
|
|
|
|
|
2 |
|
1 |
|
18,245 |
|
|
|
18,248 |
| |||||||
Cash dividends declared on common stock |
|
(16,366 |
) |
|
|
|
|
|
|
|
|
|
|
(16,366 |
) | |||||||
Treasury stock purchased |
|
|
|
|
|
|
|
(12,999 |
) |
|
|
|
|
(12,999 |
) | |||||||
Balance March 31, 2014: |
|
$ |
1,651,442 |
|
$ |
111,048 |
|
$ |
855 |
|
$ |
(757,211 |
) |
$ |
512,192 |
|
$ |
560 |
|
$ |
1,518,886 |
|
See accompanying Unaudited Notes to Condensed Consolidated Financial Statements.
AptarGroup, Inc.
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS
(Unaudited)
In thousands, brackets denote cash outflows |
|
|
|
|
| ||
|
|
|
|
|
| ||
Three Months Ended March 31, |
|
2014 |
|
2013 |
| ||
|
|
|
|
|
| ||
Cash Flows from Operating Activities: |
|
|
|
|
| ||
Net income |
|
$ |
48,408 |
|
$ |
39,978 |
|
Adjustments to reconcile net income to net cash provided by operations: |
|
|
|
|
| ||
Depreciation |
|
35,849 |
|
34,934 |
| ||
Amortization |
|
1,398 |
|
1,237 |
| ||
Stock based compensation |
|
8,396 |
|
6,534 |
| ||
Provision/(Recovery) for doubtful accounts |
|
716 |
|
(311 |
) | ||
Deferred income taxes |
|
(2,048 |
) |
(4,668 |
) | ||
Defined benefit plan expense |
|
4,226 |
|
5,123 |
| ||
Equity in results of affiliates in excess of cash distributions received |
|
1,546 |
|
262 |
| ||
Changes in balance sheet items, excluding effects from foreign currency adjustments: |
|
|
|
|
| ||
Accounts receivable |
|
(67,150 |
) |
(52,022 |
) | ||
Inventories |
|
(6,007 |
) |
(9,720 |
) | ||
Prepaid and other current assets |
|
(5,666 |
) |
(8,947 |
) | ||
Accounts payable and accrued liabilities |
|
6,320 |
|
5,528 |
| ||
Income taxes payable |
|
(5,097 |
) |
4,509 |
| ||
Retirement and deferred compensation plans |
|
(3,174 |
) |
(3,118 |
) | ||
Other changes, net |
|
14,329 |
|
6,790 |
| ||
Net Cash Provided by Operations |
|
32,046 |
|
26,109 |
| ||
|
|
|
|
|
| ||
Cash Flows from Investing Activities: |
|
|
|
|
| ||
Capital expenditures |
|
(42,914 |
) |
(34,832 |
) | ||
Disposition of property and equipment |
|
2,378 |
|
2,162 |
| ||
Net Cash Used by Investing Activities |
|
(40,536 |
) |
(32,670 |
) | ||
|
|
|
|
|
| ||
Cash Flows from Financing Activities: |
|
|
|
|
| ||
Proceeds from notes payable |
|
35,609 |
|
14,754 |
| ||
Repayments of long-term obligations |
|
(293 |
) |
(585 |
) | ||
Dividends paid |
|
(16,366 |
) |
(16,493 |
) | ||
Credit facility costs |
|
(299 |
) |
(497 |
) | ||
Proceeds from stock option exercises |
|
7,770 |
|
19,540 |
| ||
Purchase of treasury stock |
|
(12,999 |
) |
(10,768 |
) | ||
Excess tax benefit from exercise of stock options |
|
1,590 |
|
2,403 |
| ||
Net Cash Provided by Financing Activities |
|
15,012 |
|
8,354 |
| ||
|
|
|
|
|
| ||
Effect of Exchange Rate Changes on Cash |
|
794 |
|
(6,444 |
) | ||
|
|
|
|
|
| ||
Net Increase/(Decrease) in Cash and Equivalents |
|
7,316 |
|
(4,651 |
) | ||
Cash and Equivalents at Beginning of Period |
|
309,861 |
|
229,755 |
| ||
Cash and Equivalents at End of Period |
|
$ |
317,177 |
|
$ |
225,104 |
|
See accompanying Unaudited Notes to Condensed Consolidated Financial Statements.
AptarGroup, Inc.
Notes to Condensed Consolidated Financial Statements
(Amounts in Thousands, Except per Share Amounts, or Otherwise Indicated)
(Unaudited)
NOTE 1 SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES
BASIS OF PRESENTATION
The accompanying Unaudited Condensed Consolidated Financial Statements include the accounts of AptarGroup, Inc. and our subsidiaries. The terms AptarGroup or Company as used herein refer to AptarGroup, Inc. and our subsidiaries. All significant intercompany accounts and transactions have been eliminated.
In the opinion of management, the Unaudited Condensed Consolidated Financial Statements include all adjustments, consisting of only normal recurring adjustments, necessary for a fair statement of consolidated financial position, results of operations, comprehensive income, changes in equity and cash flows for the interim periods presented. The accompanying Unaudited Condensed Consolidated Financial Statements have been prepared by the Company, pursuant to the rules and regulations of the Securities and Exchange Commission (SEC). Certain information and footnote disclosure normally included in financial statements prepared in accordance with accounting principles generally accepted in the United States of America (GAAP) have been condensed or omitted pursuant to such rules and regulations, although the Company believes that the disclosures made are adequate to make the information presented not misleading. Also, certain financial position data included herein was derived from the Audited Consolidated Financial Statements included in the Companys Annual Report on Form 10-K for the year ended December 31, 2013 but does not include all disclosures required by GAAP. Accordingly, these Unaudited Condensed Consolidated Financial Statements and related notes should be read in conjunction with the Audited Consolidated Financial Statements and notes thereto included in the Companys Annual Report on Form 10-K for the year ended December 31, 2013. The results of operations of any interim period are not necessarily indicative of the results that may be expected for the year.
ADOPTION OF RECENT ACCOUNTING PRONOUNCEMENTS
Changes to GAAP are established by the Financial Accounting Standards Board (FASB) in the form of accounting standards updates to the FASBs Accounting Standards Codification.
In July 2013, the FASB issued authoritative guidance on the presentation of an unrecognized tax benefit when a net operating loss carryforward, a similar tax loss, or a tax credit carryforward exists. This standard requires an entity to present an unrecognized tax benefit, or a portion of an unrecognized tax benefit, in the financial statements as a reduction to a deferred tax asset for a net operating loss carryforward, a similar tax loss, or a tax credit carryforward. The guidance is effective for the Companys fiscal years beginning after December 15, 2013. This standard did not impact our current year financial statements as this was already the Companys existing reporting treatment.
In March 2013, the FASB issued authoritative guidance which permits an entity to release cumulative translation adjustments into net income when a reporting entity (parent) ceases to have a controlling financial interest in a subsidiary or group of assets that is a business within a foreign entity. Accordingly, the cumulative translation adjustment should be released into net income only if the sale or transfer results in the complete or substantially complete liquidation of the foreign entity in which the subsidiary or group of assets had resided, or if a controlling financial interest is no longer held. The guidance is effective for the Companys fiscal years beginning after December 15, 2013. This standard has only a minimal impact on our current year financial statements.
In February 2013, the FASB issued authoritative guidance that amends the presentation of accumulated other comprehensive income and clarifies how to report the effect of significant reclassifications out of accumulated other comprehensive income. The guidance requires footnote disclosures regarding the changes in accumulated other comprehensive income by component and the line items affected in the statements of earnings. The adoption of this standard had no impact on the Unaudited Condensed Consolidated Financial Statements other than disclosure. Additional information can be found in Note 6 of the Unaudited Notes to the Consolidated Financial Statements.
In January 2013, the FASB issued authoritative guidance requiring new asset and liability offsetting disclosures for derivatives, repurchase agreements and security lending transactions to the extent that they are offset in the financial statements or are subject to an enforceable master netting arrangement or similar agreement. We do not have any repurchase agreements and do not participate in securities lending transactions. Our derivative instruments are not offset in the financial statements. Accordingly, the adoption of this standard had no impact on the Unaudited Condensed Consolidated Financial Statements other than disclosure. Additional information can be found in Note 7 of the Unaudited Notes to the Condensed Consolidated Financial Statements.
Other accounting standards that have been issued by the FASB or other standards-setting bodies that do not require adoption until a future date are not expected to have a material impact on our Unaudited Condensed Consolidated Financial Statements upon adoption.
INCOME TAXES
The Company computes taxes on income in accordance with the tax rules and regulations of the many taxing authorities where income is earned. The income tax rates imposed by these taxing authorities may vary substantially. Taxable income may differ from pretax income for financial accounting purposes. To the extent that these differences create differences between the tax basis of an asset or liability and our reported amount in the financial statements, an appropriate provision for deferred income taxes is made.
In our determination of which foreign earnings are permanently reinvested in foreign operations, the Company considers numerous factors, including the financial requirements of the U.S. parent company and those of our foreign subsidiaries, the U.S. funding needs for dividend payments and stock repurchases, and the tax consequences of remitting earnings to the U.S. From this analysis, current year repatriation decisions are made in an attempt to provide a proper mix of debt and shareholder capital both within the U.S. and for non-U.S. operations. The Companys policy is to permanently reinvest our accumulated
foreign earnings and only will make a distribution out of current year earnings to meet the cash needs at the parent company. As such, the Company does not provide for taxes on earnings that are deemed to be permanently reinvested. Since no distribution to the U.S. of foreign earnings is expected in 2014, the effective tax rate for 2014 includes no tax cost of repatriation.
The Company provides a liability for the amount of tax benefits realized from uncertain tax positions. This liability is provided whenever the Company determines that a tax benefit will not meet a more-likely-than-not threshold for recognition. See Note 4 of the Unaudited Notes to the Condensed Consolidated Financial Statements for more information.
NOTE 2 - INVENTORIES
At March 31, 2014 and December 31, 2013, approximately 19% and 20%, respectively, of the total inventories are accounted for by the LIFO method. Inventories, by component, consisted of:
|
|
March 31, |
|
December 31, |
| ||
|
|
2014 |
|
2013 |
| ||
|
|
|
|
|
| ||
Raw materials |
|
$ |
116,976 |
|
$ |
114,501 |
|
Work in process |
|
107,450 |
|
108,924 |
| ||
Finished goods |
|
142,723 |
|
137,591 |
| ||
Total |
|
367,149 |
|
361,016 |
| ||
Less LIFO Reserve |
|
(8,440 |
) |
(7,857 |
) | ||
Total |
|
$ |
358,709 |
|
$ |
353,159 |
|
NOTE 3 GOODWILL AND OTHER INTANGIBLE ASSETS
The changes in the carrying amount of goodwill since the year ended December 31, 2013 are as follows by reporting segment:
|
|
Beauty + |
|
|
|
Food + |
|
Corporate |
|
|
| |||||
|
|
Home |
|
Pharma |
|
Beverage |
|
& Other |
|
Total |
| |||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Goodwill |
|
$ |
181,002 |
|
$ |
159,949 |
|
$ |
17,914 |
|
$ |
1,615 |
|
$ |
360,480 |
|
Accumulated impairment losses |
|
-- |
|
-- |
|
-- |
|
(1,615 |
) |
(1,615 |
) | |||||
Balance as of December 31, 2013 |
|
$ |
181,002 |
|
$ |
159,949 |
|
$ |
17,914 |
|
$ |
-- |
|
$ |
358,865 |
|
Acquisition |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
| |||||
Foreign currency exchange effects |
|
345 |
|
489 |
|
(18 |
) |
-- |
|
816 |
| |||||
Goodwill |
|
$ |
181,347 |
|
$ |
160,438 |
|
$ |
17,896 |
|
$ |
1,615 |
|
$ |
361,296 |
|
Accumulated impairment losses |
|
-- |
|
-- |
|
-- |
|
(1,615 |
) |
(1,615 |
) | |||||
Balance as of March 31, 2014 |
|
$ |
181,347 |
|
$ |
160,438 |
|
$ |
17,896 |
|
$ |
-- |
|
$ |
359,681 |
|
The table below shows a summary of intangible assets as of March 31, 2014 and December 31, 2013.
|
|
|
|
March 31, 2014 |
|
December 31, 2013 |
| ||||||||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Weighted Average |
|
Gross |
|
|
|
|
|
Gross |
|
|
|
|
| ||||||||
Amortization |
|
Carrying |
|
Accumulated |
|
Net |
|
Carrying |
|
Accumulated |
|
Net |
| ||||||||
Period (Years) |
|
Amount |
|
Amortization |
|
Value |
|
Amount |
|
Amortization |
|
Value |
| ||||||||
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Amortized intangible assets: |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||||
Patents |
|
7 |
|
$ |
20,210 |
|
$ |
(19,842 |
) |
$ |
368 |
|
$ |
20,165 |
|
$ |
(19,732 |
) |
$ |
433 |
|
Acquired Technology |
|
15 |
|
40,641 |
|
(4,742 |
) |
35,899 |
|
40,546 |
|
(4,055 |
) |
36,491 |
| ||||||
License agreements and other |
|
5 |
|
35,650 |
|
(22,953 |
) |
12,697 |
|
35,259 |
|
(22,232 |
) |
13,027 |
| ||||||
Total intangible assets |
|
10 |
|
$ |
96,501 |
|
$ |
(47,537 |
) |
$ |
48,964 |
|
$ |
95,970 |
|
$ |
(46,019 |
) |
$ |
49,951 |
|
Aggregate amortization expense for the intangible assets above for the quarters ended March 31, 2014 and 2013 was $1,398 and $1,237, respectively.
Future estimated amortization expense for the years ending December 31 is as follows:
2014 |
|
$ |
4,133 |
(remaining estimated amortization for 2014) |
|
2015 |
|
5,349 |
|
| |
2016 |
|
4,343 |
|
| |
2017 |
|
3,619 |
|
| |
2018 and thereafter |
|
31,520 |
|
|
Future amortization expense may fluctuate depending on changes in foreign currency rates. The estimates for amortization expense noted above are based upon foreign exchange rates as of March 31, 2014.
NOTE 4 INCOME TAX UNCERTAINTIES
The Company had approximately $7.2 and $8.0 million recorded for income tax uncertainties as of March 31, 2014 and December 31, 2013, respectively. The $0.8 million change in income tax uncertainties was primarily the result of an audit settlement in the U.S. The amount, if recognized, that would impact the effective tax rate is $7.0 and $7.8 million, respectively. The Company estimates that it is reasonably possible that the liability for uncertain tax positions will decrease by no more than $5 million in the next twelve months from the resolution of various uncertain positions as a result of the completion of tax audits, litigation and the expiration of the statute of limitations in various jurisdictions.
NOTE 5 RETIREMENT AND DEFERRED COMPENSATION PLANS
Components of Net Periodic Benefit Cost:
|
|
Domestic Plans |
|
Foreign Plans |
| ||||||||
Three months ended March 31, |
|
2014 |
|
2013 |
|
2014 |
|
2013 |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Service cost |
|
$ |
2,011 |
|
$ |
2,225 |
|
$ |
1,079 |
|
$ |
969 |
|
Interest cost |
|
1,482 |
|
1,250 |
|
699 |
|
665 |
| ||||
Expected return on plan assets |
|
(1,646 |
) |
(1,414 |
) |
(510 |
) |
(452 |
) | ||||
Amortization of net loss |
|
717 |
|
1,434 |
|
313 |
|
352 |
| ||||
Amortization of prior service cost |
|
-- |
|
1 |
|
81 |
|
93 |
| ||||
Net periodic benefit cost |
|
$ |
2,564 |
|
$ |
3,496 |
|
$ |
1,662 |
|
$ |
1,627 |
|
EMPLOYER CONTRIBUTIONS
Although the Company has no minimum funding requirement, we plan to contribute approximately $10 million to our domestic defined benefit plans in 2014. No 2014 contributions were made as of March 31, 2014. The Company also expects to contribute approximately $5.6 million to our foreign defined benefit plans in 2014 and, as of March 31, 2014, we have contributed approximately $0.8 million.
NOTE 6 ACCUMULATED OTHER COMPREHENSIVE INCOME
Changes in Accumulated Other Comprehensive Income by Component:
|
|
Foreign |
|
Defined Benefit |
|
Other |
|
Total |
| ||||||||
|
|
|
|
|
|
|
|
|
| ||||||||
Balance December 31, 2012 |
|
$ |
|
120,097 |
|
$ |
|
(59,248 |
) |
$ |
|
(166 |
) |
$ |
|
60,683 |
|
Other comprehensive income before reclassifications |
|
(35,614 |
) |
-- |
|
-- |
|
(35,614 |
) | ||||||||
Amounts reclassified from accumulated other comprehensive income |
|
-- |
|
1,179 |
|
15 |
|
1,194 |
| ||||||||
Net current-period other comprehensive income |
|
(35,614 |
) |
1,179 |
|
15 |
|
(34,420 |
) | ||||||||
Balance - March 31, 2013 |
|
$ |
|
84,483 |
|
$ |
|
(58,069 |
) |
$ |
|
(151 |
) |
$ |
|
26,263 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| ||||
Balance December 31, 2013 |
|
$ |
|
149,965 |
|
$ |
|
(40,093 |
) |
$ |
|
(121 |
) |
$ |
|
109,751 |
|
Other comprehensive income before reclassifications |
|
913 |
|
-- |
|
-- |
|
913 |
| ||||||||
Amounts reclassified from accumulated other comprehensive income |
|
(340 |
) |
718 |
|
6 |
|
384 |
| ||||||||
Net current-period other comprehensive income |
|
573 |
|
718 |
|
6 |
|
1,297 |
| ||||||||
Balance - March 31, 2014 |
|
$ |
|
150,538 |
|
$ |
|
(39,375 |
) |
$ |
|
(115 |
) |
$ |
|
111,048 |
|
Reclassifications Out of Accumulated Other Comprehensive Income:
Details about Accumulated Other |
|
Amount Reclassified from Accumulated |
|
Affected Line in the Statement | ||||
Comprehensive Income Components |
|
Other Comprehensive Income |
|
Where Net Income is Presented | ||||
Three months ended March 31, |
|
2014 |
|
2013 |
|
| ||
|
|
|
|
|
|
| ||
Defined Benefit Pension Plans |
|
|
|
|
|
| ||
Amortization of net loss |
|
$ |
1,030 |
|
$ |
1,786 |
|
(a) |
Amortization of prior service cost |
|
81 |
|
94 |
|
(a) | ||
|
|
1,111 |
|
1,880 |
|
Total before tax | ||
|
|
(393 |
) |
(701 |
) |
Tax benefit | ||
|
|
$ |
718 |
|
$ |
1,179 |
|
Net of tax |
|
|
|
|
|
|
| ||
Foreign Currency |
|
|
|
|
|
| ||
Foreign Currency Gain |
|
(340 |
) |
-- |
|
Miscellaneous, net | ||
|
|
(340 |
) |
-- |
|
Total before tax | ||
|
|
-- |
|
-- |
|
Tax benefit | ||
|
|
$ |
(340 |
) |
$ |
-- |
|
Net of tax |
Other |
|
|
|
|
|
| ||
Changes in treasury locks |
|
9 |
|
23 |
|
Interest Expense | ||
|
|
9 |
|
23 |
|
Total before tax | ||
|
|
(3 |
) |
(8 |
) |
Tax benefit | ||
|
|
$ |
6 |
|
$ |
15 |
|
Net of tax |
Total reclassifications for the period |
|
$ |
384 |
|
$ |
1,194 |
|
|
(a) These accumulated other comprehensive income components are included in the computation of net periodic benefit costs, net of tax (see Note 5 Retirement and Deferred Compensation Plans for additional details).
NOTE 7 DERIVATIVE INSTRUMENTS AND HEDGING ACTIVITIES
The Company maintains a foreign exchange risk management policy designed to establish a framework to protect the value of the Companys non-functional denominated transactions from adverse changes in exchange rates. Sales of the Companys products can be denominated in a currency different from the currency in which the related costs to produce the product are denominated. Changes in exchange rates on such inter-country sales or intercompany loans can impact the Companys results of operations. The Companys policy is not to engage in speculative foreign currency hedging activities, but to minimize our net foreign currency transaction exposure defined as firm commitments and transactions recorded and denominated in currencies other than the functional currency. The Company may use foreign currency forward exchange contracts, options and cross currency swaps to economically hedge these risks.
The Company maintains an interest rate risk management strategy to minimize significant, unanticipated earnings fluctuations that may arise from volatility in interest rates.
For derivative instruments designated as hedges, the Company formally documents the nature and relationships between the hedging instruments and the hedged items, as well as the risk management objectives, strategies for undertaking the various hedge transactions, and the method of assessing hedge effectiveness. Additionally, in order to designate any derivative instrument as a hedge of an anticipated transaction, the significant characteristics and expected terms of any anticipated transaction must be specifically identified, and it must be probable that the anticipated transaction will occur.
HEDGE OF NET INVESTMENTS IN FOREIGN OPERATIONS
A significant number of the Companys operations are located outside of the United States. Because of this, movements in exchange rates may have a significant impact on the translation of the financial condition and results of operations of the Companys foreign entities. A strengthening U.S. dollar relative to foreign currencies has a dilutive translation effect on the Companys financial condition and results of operations. Conversely, a weakening U.S. dollar has an additive effect. The Company in some cases maintains debt in these subsidiaries to offset the net asset exposure. The Company does not otherwise actively manage this risk using derivative financial instruments. In the event the Company plans on a full or partial liquidation of any of our foreign subsidiaries where the Companys net investment is likely to be monetized, the Company will consider hedging the currency exposure associated with such a transaction.
OTHER
As of March 31, 2014, the Company has recorded the fair value of foreign currency forward exchange contracts of $1.1 million in prepaid and other, $0.1 million in miscellaneous other assets, $1.2 million in accounts payable and accrued liabilities, and $0.1 million in deferred and other non-current liabilities in the balance sheet. All forward exchange contracts outstanding as of March 31, 2014 had an aggregate contract amount of $146 million.
Fair Value of Derivative Instruments in the Condensed Consolidated Balance Sheets as of March 31, 2014
and December 31, 2013
Derivative Contracts Not Designated |
|
Balance Sheet |
|
March 31, |
|
December |
| ||
|
|
|
|
|
|
|
| ||
Derivative Assets |
|
|
|
|
|
|
| ||
Foreign Exchange Contracts |
|
Prepaid and other |
|
$ |
1,124 |
|
$ |
3,003 |
|
Foreign Exchange Contracts |
|
Miscellaneous Other Assets |
|
62 |
|
985 |
| ||
|
|
|
|
$ |
1,186 |
|
$ |
3,988 |
|
Derivative Liabilities |
|
|
|
|
|
|
| ||
Foreign Exchange Contracts |
|
Accounts payable and accrued liabilities |
|
$ |
1,168 |
|
$ |
522 |
|
Foreign Exchange Contracts |
|
Deferred and other non-current liabilities |
|
75 |
|
110 |
| ||
|
|
|
|
$ |
1,243 |
|
$ |
632 |
|
The Effect of Derivative Instruments on the Condensed Consolidated Statements of Income
for the Quarters Ended March 31, 2014 and March 31, 2013
Derivatives Not Designated as |
|
Location of Gain or (Loss) Recognized in |
|
Amount of Gain or (Loss) |
| ||||
|
|
|
|
2014 |
|
2013 |
| ||
|
|
|
|
|
|
|
| ||
Foreign Exchange Contracts |
|
Other Income (Expense) Miscellaneous, net |
|
$ |
(159 |
) |
$ |
(2,598 |
) |
|
|
|
|
$ |
(159 |
) |
$ |
(2,598 |
) |
|
|
|
|
|
|
Net Amounts |
|
Gross Amounts not Offset in the |
|
|
| |||||
|
|
|
|
Gross Amounts |
|
Presented in |
|
Statement of Financial Position |
|
|
| |||||
|
|
Gross |
|
Offset in the |
|
the Statement of |
|
Financial |
|
Cash Collateral |
|
Net |
| |||
|
|
Amount |
|
Financial Position |
|
Financial Position |
|
Instruments |
|
Received |
|
Amount |
| |||
Description |
|
|
|
|
|
|
|
|
|
|
|
|
| |||
March 31, 2014 |
|
|
|
|
|
|
|
|
|
|
|
|
| |||
Derivative Assets |
|
$ |
1,186 |
|
-- |
|
$ |
1,186 |
|
-- |
|
-- |
|
$ |
1,186 |
|
Total Assets |
|
$ |
1,186 |
|
-- |
|
$ |
1,186 |
|
-- |
|
-- |
|
$ |
1,186 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative Liabilities |
|
$ |
1,243 |
|
-- |
|
$ |
1,243 |
|
-- |
|
-- |
|
$ |
1,243 |
|
Total Liabilities |
|
$ |
1,243 |
|
-- |
|
$ |
1,243 |
|
-- |
|
-- |
|
$ |
1,243 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| |||
December 31, 2013 |
|
|
|
|
|
|
|
|
|
|
|
|
| |||
Derivative Assets |
|
$ |
3,988 |
|
-- |
|
$ |
3,988 |
|
-- |
|
-- |
|
$ |
3,988 |
|
Total Assets |
|
$ |
3,988 |
|
-- |
|
$ |
3,988 |
|
-- |
|
-- |
|
$ |
3,988 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Derivative Liabilities |
|
$ |
632 |
|
-- |
|
$ |
632 |
|
-- |
|
-- |
|
$ |
632 |
|
Total Liabilities |
|
$ |
632 |
|
-- |
|
$ |
632 |
|
-- |
|
-- |
|
$ |
632 |
|
NOTE 8 FAIR VALUE
Authoritative guidelines require the categorization of assets and liabilities into three levels based upon the assumptions (inputs) used to price the assets or liabilities. Level 1 provides the most reliable measure of fair value, whereas Level 3 generally requires significant management judgment. The three levels are defined as follows:
· Level 1: Unadjusted quoted prices in active markets for identical assets and liabilities.
· Level 2: Observable inputs other than those included in Level 1. For example, quoted prices for similar assets or liabilities in active markets or quoted prices for identical assets or liabilities in inactive markets.
· Level 3: Unobservable inputs reflecting managements own assumptions about the inputs used in pricing the asset or liability.
As of March 31, 2014, the fair values of our financial assets and liabilities were categorized as follows:
|
|
Total |
|
Level 1 |
|
Level 2 |
|
Level 3 |
| ||||
Assets |
|
|
|
|
|
|
|
|
| ||||
Forward exchange contracts (a) |
|
$ |
1,186 |
|
$ |
-- |
|
$ |
1,186 |
|
$ |
-- |
|
Total assets at fair value |
|
$ |
1,186 |
|
$ |
-- |
|
$ |
1,186 |
|
$ |
-- |
|
|
|
|
|
|
|
|
|
|
| ||||
Liabilities |
|
|
|
|
|
|
|
|
| ||||
Forward exchange contracts (a) |
|
$ |
1,243 |
|
$ |
-- |
|
$ |
1,243 |
|
$ |
-- |
|
Total liabilities at fair value |
|
$ |
1,243 |
|
$ |
-- |
|
$ |
1,243 |
|
$ |
-- |
|
As of December 31, 2013, the fair values of our financial assets and liabilities were categorized as follows:
|
|
Total |
|
Level 1 |
|
Level 2 |
|
Level 3 |
| ||||
Assets |
|
|
|
|
|
|
|
|
| ||||
Forward exchange contracts (a) |
|
$ |
3,988 |
|
$ |
-- |
|
$ |
3,988 |
|
$ |
-- |
|
Total assets at fair value |
|
$ |
3,988 |
|
$ |
-- |
|
$ |
3,988 |
|
$ |
-- |
|
|
|
|
|
|
|
|
|
|
| ||||
Liabilities |
|
|
|
|
|
|
|
|
| ||||
Forward exchange contracts (a) |
|
$ |
632 |
|
$ |
-- |
|
$ |
632 |
|
$ |
-- |
|
Total liabilities at fair value |
|
$ |
632 |
|
$ |
-- |
|
$ |
632 |
|
$ |
-- |
|
(a) Market approach valuation technique based on observable market transactions of spot and forward rates.
The carrying amounts of the Companys other current financial instruments such as cash and equivalents, notes payable and current maturities of long-term obligations approximate fair value due to the short-term maturity of the instrument. The Company considers our long-term obligations a Level 2 liability and utilizes the market approach valuation technique based on interest rates that are currently available to the Company for issuance of debt with similar terms and maturities. The estimated fair value of the Companys long-term obligations was $368 million as of March 31, 2014 and $363 million as of December 31, 2013.
NOTE 9 - COMMITMENTS AND CONTINGENCIES
The Company, in the normal course of business, is subject to a number of lawsuits and claims both actual and potential in nature, including the proceeding noted below. While management believes the resolution of these claims and lawsuits will not have a material adverse effect on the Companys financial position or results of operations or cash flows, claims and legal proceedings are subject to inherent uncertainties, and unfavorable outcomes could occur that could include amounts in excess of any accruals which management has established. Were such unfavorable final outcomes to occur, it is possible that they could have a material adverse effect on our financial position, results of operations and cash flows.
In 2010, a competitor filed a lawsuit against certain AptarGroup, Inc. subsidiaries alleging that certain processes performed by a supplier of a specific type of diptube utilized by the AptarGroup, Inc. subsidiaries in the manufacture of a specific type of pump infringes patents owned by the counterparty. This lawsuit sought an injunction barring the manufacture, use, sale and importation of this specific pump for use in fragrance containers. In April 2012, the Companys United States subsidiary was found to have infringed on patents owned by the counterparty within the United States. The ruling does not apply to the manufacture or sales of pumps in countries outside the United States and no damages were assessed. The Company pursued the issue in the Appellate Court, where certain rulings were confirmed and others were returned to the district court, where a trial date was set for March 2014. On February 13, 2014, the parties agreed to a license agreement, effectively ending the lawsuit and its related costs.
Under our Certificate of Incorporation, the Company has agreed to indemnify our officers and directors for certain events or occurrences while the officer or director is, or was, serving at our request in such capacity. The maximum potential amount of future payments the Company could be required to make under these indemnification agreements is unlimited; however, the Company has a directors and officers liability insurance policy that covers a portion of our exposure. As a result of our insurance policy coverage, the Company believes the estimated fair value of these indemnification agreements is minimal. The Company has no liabilities recorded for these agreements as of March 31, 2014.
NOTE 10 STOCK REPURCHASE PROGRAM
During the three months ended March 31, 2014, the Company repurchased approximately 200 thousand shares for approximately $13.0 million. As of March 31, 2014, the Company has a remaining authorization to repurchase 3.8 million additional shares. The timing of and total amount expended for the share repurchase depends upon market conditions.
NOTE 11 STOCK-BASED COMPENSATION
The Company issues stock options and restricted stock units to employees under Stock Awards Plans approved by shareholders. Stock options are issued to non-employee directors for their services as directors under Director Stock Option Plans approved by shareholders. Options are awarded with the exercise price equal to the market price on the date of grant and generally become exercisable over three years and expire 10 years after grant. Restricted stock units generally vest over three years.
Compensation expense recorded attributable to stock options for the first three months of 2014 was approximately $8.4 million ($5.5 million after tax). The income tax benefit related to this compensation expense was approximately $2.9 million. Approximately $7.6 million of the compensation expense was recorded in selling, research & development and administrative expenses and the balance was recorded in cost of sales. Compensation expense recorded attributable to stock options for the first three months of 2013 was approximately $6.5 million ($4.4 million after tax). The income tax benefit related to this compensation expense was approximately $2.1 million. Approximately $5.9 million of the compensation expense was recorded in selling, research & development and administrative expenses and the balance was recorded in cost of sales.
The Company uses historical data to estimate expected life and volatility. The weighted-average fair value of stock options granted under the Stock Awards Plans was $14.84 and $10.07 per share in 2014 and 2013, respectively. These values were estimated on the respective dates of grant using the Black-Scholes option-pricing model with the following weighted-average assumptions:
Stock Awards Plans: |
|
|
|
|
|
Three months ended March 31, |
|
2014 |
|
2013 |
|
|
|
|
|
|
|
Dividend Yield |
|
1.7 |
% |
1.8 |
% |
Expected Stock Price Volatility |
|
22.2 |
% |
22.7 |
% |
Risk-free Interest Rate |
|
2.3 |
% |
1.2 |
% |
Expected Life of Option (years) |
|
6.9 |
|
6.9 |
|
There were no grants under the Director Stock Option Plan during the three months ended March 31, 2014 and 2013.
A summary of option activity under the Companys stock plans as of March 31, 2014, and changes during the three months then ended is presented below:
|
|
Stock Awards Plans |
|
Director Stock Option Plans |
| ||||||||
|
|
|
|
Weighted Average |
|
|
|
Weighted Average |
| ||||
|
|
Shares |
|
Exercise Price |
|
Shares |
|
Exercise Price |
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Outstanding, January 1, 2014 |
|
7,815,932 |
|
$ |
41.26 |
|
313,834 |
|
$ |
48.85 |
| ||
Granted |
|
1,349,850 |
|
68.00 |
|
-- |
|
-- |
| ||||
Exercised |
|
(216,498 |
) |
33.82 |
|
-- |
|
-- |
| ||||
Forfeited or expired |
|
(19,400 |
) |
50.18 |
|
-- |
|
-- |
| ||||
Outstanding at March 31, 2014 |
|
8,929,884 |
|
$ |
45.47 |
|
313,834 |
|
$ |
48.85 |
| ||
Exercisable at March 31, 2014 |
|
6,252,800 |
|
$ |
39.23 |
|
146,000 |
|
$ |
42.05 |
| ||
|
|
|
|
|
|
|
|
|
| ||||
Weighted-Average Remaining Contractual Term (Years): |
|
|
|
|
| ||||||||
Outstanding at March 31, 2014 |
|
6.5 |
|
|
|
7.3 |
|
|
| ||||
Exercisable at March 31, 2014 |
|
5.3 |
|
|
|
5.9 |
|
|
| ||||
|
|
|
|
|
|
|
|
|
| ||||
Aggregate Intrinsic Value ($000): |
|
|
|
|
|
|
|
|
| ||||
Outstanding at March 31, 2014 |
|
$ |
186,827 |
|
|
|
$ |
5,415 |
|
|
| ||
Exercisable at March 31, 2014 |
|
$ |
168,000 |
|
|
|
$ |
3,511 |
|
|
| ||
|
|
|
|
|
|
|
|
|
| ||||
Intrinsic Value of Options Exercised ($000) During the Three Months Ended: |
|
|
|
|
| ||||||||
March 31, 2014 |
|
$ |
6,912 |
|
|
|
$ |
-- |
|
|
| ||
March 31, 2013 |
|
$ |
16,515 |
|
|
|
$ |
-- |
|
|
|
The fair value of shares vested during the three months ended March 31, 2014 and 2013 was $13.0 million and $12.1 million, respectively. Cash received from option exercises was approximately $2.4 million and the actual tax benefit realized for the tax deduction from option exercises was approximately $7.8 million in the three months ended March 31, 2014. As of March 31, 2014, the remaining valuation of stock option awards to be expensed in future periods was $21.0 million and the related weighted-average period over which it is expected to be recognized is 1.6 years.
The fair value of restricted stock unit grants is the market price of the underlying shares on the grant date. A summary of restricted stock unit activity as of March 31, 2014, and changes during the period then ended is presented below:
|
|
|
|
Weighted-Average |
| |
|
|
Shares |
|
Grant-Date Fair Value |
| |
|
|
|
|
|
| |
Nonvested at January 1, 2014 |
|
25,681 |
|
$ |
53.49 |
|
Granted |
|
43,671 |
|
67.57 |
| |
Vested |
|
(9,355 |
) |
52.50 |
| |
Nonvested at March 31, 2014 |
|
59,997 |
|
$ |
63.90 |
|
Compensation expense recorded attributable to restricted stock unit grants for the first three months of 2014 and 2013 was approximately $733 thousand and $416 thousand, respectively. The fair value of units vested during the three months ended March 31, 2014 and 2013 was $491 thousand and $496 thousand, respectively. The intrinsic value of units vested during the three months ended March 31, 2014 and 2013 was $613 thousand and $582 thousand, respectively. As of March 31, 2014 there was $2.7 million of total unrecognized compensation cost relating to restricted stock unit awards which is expected to be recognized over a weighted-average period of 1.8 years.
During the first quarter of 2014, the Company approved a new long-term incentive program for certain employees. The program is based on the cumulative total shareholder return of our common stock during a three year performance period. Total expense related to this program is expected to be approximately $1.2 million over the performance period, of which $159 thousand was recognized in the first quarter of 2014.
NOTE 12 EARNINGS PER SHARE
AptarGroups authorized common stock consists of 199 million shares, having a par value of $.01 each. Information related to the calculation of earnings per share is as follows:
|
|
March 31, 2014 |
|
March 31, 2013 |
| ||||||||
|
|
Diluted |
|
Basic |
|
Diluted |
|
Basic |
| ||||
Consolidated operations |
|
|
|
|
|
|
|
|
| ||||
Income available to common shareholders |
|
$ |
48,389 |
|
$ |
48,389 |
|
$ |
40,029 |
|
$ |
40,029 |
|
|
|
|
|
|
|
|
|
|
| ||||
Average equivalent shares |
|
|
|
|
|
|
|
|
| ||||
Shares of common stock |
|
65,468 |
|
65,468 |
|
66,155 |
|
66,155 |
| ||||
Effect of dilutive stock based compensation |
|
|
|
|
|
|
|
|
| ||||
Stock options |
|
2,738 |
|
-- |
|
2,133 |
|
-- |
| ||||
Restricted stock |
|
26 |
|
-- |
|
8 |
|
-- |
| ||||
Total average equivalent shares |
|
68,232 |
|
65,468 |
|
68,296 |
|
66,155 |
| ||||
Net income per share |
|
$ |
.71 |
|
$ |
.74 |
|
$ |
.59 |
|
$ |
.61 |
|
NOTE 13 SEGMENT INFORMATION
The Company operates in the packaging components industry, which includes the development, manufacture and sale of consumer product dispensing solutions. The Company is organized into three reporting segments. Operations that sell dispensing systems primarily to the personal care, beauty and home care markets form the Beauty + Home segment. Operations that sell dispensing systems primarily to the prescription drug, consumer health care and injectables markets form the Pharma segment. Operations that sell dispensing systems primarily to the food and beverage markets form the Food + Beverage segment.
The accounting policies of the segments are the same as those described in Note 1, Summary of Significant Accounting Policies in the Companys Annual Report on Form 10-K for the year ended December 31, 2013. Segment income is defined as earnings before net interest expense, certain corporate expenses, restructuring initiatives and related depreciation and income taxes.
Financial information regarding the Companys reportable segments is shown below:
Three months ended March 31, |
|
2014 |
|
2013 |
| ||
|
|
|
|
|
| ||
Total Revenue: |
|
|
|
|
| ||
Beauty + Home |
|
$ |
398,540 |
|
$ |
367,183 |
|
Pharma |
|
194,349 |
|
168,893 |
| ||
Food + Beverage |
|
90,626 |
|
85,333 |
| ||
Total Revenue |
|
$ |
683,515 |
|
$ |
621,409 |
|
|
|
|
|
|
| ||
Less: Intersegment Sales: |
|
|
|
|
| ||
Beauty + Home |
|
$ |
7,304 |
|
$ |
3,711 |
|
Pharma |
|
-- |
|
24 |
| ||
Food + Beverage |
|
160 |
|
41 |
| ||
Total Intersegment Sales |
|
$ |
7,464 |
|
$ |
3,776 |
|
|
|
|
|
|
| ||
Net Sales: |
|
|
|
|
| ||
Beauty + Home |
|
$ |
391,236 |
|
$ |
363,472 |
|
Pharma |
|
194,349 |
|
168,869 |
| ||
Food + Beverage |
|
90,466 |
|
85,292 |
| ||
Net Sales |
|
$ |
676,051 |
|
$ |
617,633 |
|
|
|
|
|
|
| ||
Segment Income (1): |
|
|
|
|
| ||
Beauty + Home |
|
$ |
27,781 |
|
$ |
24,415 |
|
Pharma |
|
52,482 |
|
45,980 |
| ||
Food + Beverage |
|
9,080 |
|
8,550 |
| ||
Restructuring Initiatives and Related Depreciation |
|
-- |
|
(4,526 |
) | ||
Corporate & Other |
|
(11,798 |
) |
(10,785 |
) | ||
Income before interest and taxes |
|
$ |
77,545 |
|
$ |
63,634 |
|
Interest expense, net |
|
(3,865 |
) |
(4,232 |
) | ||
Income before income taxes |
|
$ |
73,680 |
|
$ |
59,402 |
|
(1) The Company evaluates performance of our business units and allocates resources based upon segment income. Segment income is defined as earnings before net interest expense, certain corporate expenses, restructuring initiatives and income taxes. Restructuring Initiatives and Related Depreciation includes the following income/(expense) items for the three months ended March 31, 2014 as follows:
Three months ended March 31, |
|
2014 |
|
2013 |
| ||
|
|
|
|
|
| ||
European Restructuring Plan |
|
|
|
|
| ||
Depreciation |
|
$ |
-- |
|
$ |
459 |
|
Employee Severance and Other Costs |
|
-- |
|
4,067 |
| ||
Total Restructuring Initiatives and Related Depreciation Expense |
|
$ |
-- |
|
$ |
4,526 |
|
Restructuring Initiatives and Related Depreciation Expense by Segment |
|
|
|
|
| ||
Beauty + Home |
|
$ |
-- |
|
$ |
4,526 |
|
Total Restructuring Initiatives and Related Depreciation Expense |
|
$ |
-- |
|
$ |
4,526 |
|
NOTE 14 ACQUISITIONS
In December 2013, AptarGroup acquired a 20% non-controlling investment in Bapco Closures Holding Limited (Bapco) for approximately $5.2 million. In addition to this equity stake, the Company secured an exclusive global license related to innovative closures sealing technology that provides package integrity and tamper evidence. This investment is being accounted for under the equity method of accounting from the date of acquisition and since it does not have a material impact on the results of operations in 2014 or 2013, pro forma information is not presented.
NOTE 15 RESTRUCTURING INITIATIVES
in November 2012, the Company announced a plan to optimize certain capacity in Europe. Due to increased production efficiencies and to better position the Company for future growth in Europe, AptarGroup transferred and consolidated production capacity involving twelve facilities. Two facilities have closed impacting approximately 170 employees. The locations involved in the plan are facilities serving the beauty, personal care, food, beverage, and consumer health care markets. As of December 31, 2013, the plan was substantially complete. The cumulative expense incurred was $19.5 million. As of March 31, 2014 we have recorded the following activity associated with our European restructuring plan:
|
|
Beginning |
|
Net Charges for |
|
|
|
|
|
Ending |
| |||||
|
|
Reserve at |
|
the Three Months |
|
|
|
|
|
Reserve at |
| |||||
|
|
12/31/13 |
|
Ended 3/31/14 |
|
Cash Paid |
|
FX Impact |
|
3/31/14 |
| |||||
|
|
|
|
|
|
|
|
|
|
|
| |||||
Employee severance |
|
$ |
2,521 |
|
$ |
-- |
|
$ |
(1,880 |
) |
$ |
(1 |
) |
$ |
640 |
|
Other costs |
|
1,735 |
|
-- |
|
(492 |
) |
13 |
|
1,256 |
| |||||
Totals |
|
$ |
4,256 |
|
$ |
-- |
|
$ |
(2,372 |
) |
$ |
12 |
|
$ |
1,896 |
|
ITEM 2. MANAGEMENTS DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS
(AMOUNTS IN THOUSANDS, EXCEPT PER SHARE AMOUNTS, OR OTHERWISE INDICATED)
RESULTS OF OPERATIONS
|
|
|
|
|
|
|
|
|
|
|
|
Quarter Ended March 31, |
|
2014 |
|
2013 |
|
|
|
|
|
|
|
Net Sales |
|
100.0 |
% |
100.0 |
% |
Cost of sales (exclusive of depreciation and amortization shown below) |
|
67.1 |
|
67.8 |
|
Selling, research & development and administrative |
|
15.8 |
|
15.3 |
|
Depreciation and amortization |
|
5.5 |
|
5.9 |
|